Fidelity Investments’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$627K Buy
14,490
+2,174
+18% +$92.1K ﹤0.01% 3192
2026
Q1
$480K Sell
12,316
-1,590
-11% -$64.5K ﹤0.01% 3145
2025
Q4
$568K Buy
13,906
+11,857
+579% +$483K ﹤0.01% 3036
2025
Q3
$82.7K Sell
2,049
-133
-6% -$5.13K ﹤0.01% 3743
2025
Q2
$80.3K Buy
2,182
+1,163
+114% +$39.4K ﹤0.01% 3697
2025
Q1
$33.8K Buy
1,019
+218
+27% +$7.58K ﹤0.01% 4029
2024
Q4
$27.7K Buy
801
+261
+48% +$9.16K ﹤0.01% 4102
2024
Q3
$18.3K Buy
540
+340
+170% +$11.1K ﹤0.01% 4215
2024
Q2
$6.45K Hold
200
﹤0.01% 4473
2024
Q1
$6.2K Buy
+200
New +$5.85K ﹤0.01% 4439

Other funds holding RECS

Fidelity Investments's RECS Position: Q2 2026 in Review

Fidelity Investments increased its Columbia Research Enhanced Core ETF (RECS) stake by 18% in Q2 2026, buying an estimated $92.1K and bringing the position to 14,490 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

Fidelity Investments first reported a position in RECS in Q1 2024 and has held it in 10 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Fidelity Investments held 14,490 shares of Columbia Research Enhanced Core ETF worth $627K as of Q2 2026.
  • Fidelity Investments bought 2,174 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $92.1K.
  • Columbia Research Enhanced Core ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3192 holding.
  • Fidelity Investments first reported a position in Columbia Research Enhanced Core ETF in Q1 2024 and has held it in 10 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.